MD-IONQ
IonQ (NYSE: IONQ), a leader in the quantum computing industry, today announced early results from its work with Deutsches Elektronen-Synchrotron (DESY) – a German-based research center for fundamental science – to run combinatorial optimization problems on IonQ Aria. The results demonstrate quantum computing’s potential as a more effective solution than traditional classical computing when tackling equations with multiple variables in a dense environment, such as a bustling airport.
IonQ collaborated with researchers from DESY to explore how to better match inbound and outbound flights at airport gates. Specifically, IonQ and DESY were interested in reducing the time travelers spent going from arrival to departure gates and the time planes sat idle at gates before taking off again, while also increasing the number of planes serviced per day at a gate. The novel approach used ‘logarithmic-linear encoding’ to execute flight-gate optimization algorithms on IonQ Aria. In an illustrative example, the team showed how to best cycle nine flights through four gates (up to 36 variables in total) on IonQ Aria. IonQ expects to run future algorithms on IonQ Forte and IonQ Tempo, processing equations sufficient enough to cover the optimization needs of a local European airport.
“The results of our work with DESY are indicative of the real-world value quantum computers can deliver when addressing optimization problems that factor dozens of variable scenarios,” said Peter Chapman, CEO and President of IonQ. “Optimization problems are ubiquitous across all industries, including manufacturing, logistics, finance, pharma, and more. Quantum computing presents a huge opportunity for businesses to innovate across this problem space and remain at the forefront of innovation, tackling problems once deemed unsolvable.”
"We are pleased by the initial results we’re seeing in running quadratic assignment problems across IonQ’s quantum hardware and our collaboration with the IonQ team,” said Dr. Karl Jansen, the head of the Center for Quantum Technology and Applications (CQTA) at DESY. "The learnings gathered here can easily apply to other research and industries where the presence of multiple variables creates too complex of a problem for classical systems to handle."
A preprint explaining IonQ and DESY’s research is available here, with the final report expected to be published in the coming months, and a summary of these results is available on IonQ’s blog here.
These research results mark the latest effort by IonQ to support the development of quantum applications for the airline industry. In 2022, IonQ and Airbus partnered on a project to develop smarter algorithms based on quantum computers to achieve cost savings due to more efficient cargo loading and distribution. Additionally, Hyundai Motors and Thompson Machinery have partnered with IonQ to develop quantum applications for use cases like image recognition in autonomous vehicles and predictive maintenance for construction machinery.
To learn more about how you can get started on an IonQ system today, please contact us directly at: https://ionq.com/get-ready.
About IonQ
IonQ, Inc. is a leader in quantum computing that delivers high-performance systems capable of solving the world’s largest and most complex commercial and research use cases. IonQ’s current generation quantum computer, IonQ Forte, is the latest in a line of cutting-edge systems, boasting 36 algorithmic qubits. The company’s innovative technology and rapid growth were recognized in Fast Company’s 2023 Next Big Things in Tech List and Deloitte’s 2023 Technology Fast 500™ List, respectively. Available through all major cloud providers, IonQ is making quantum computing more accessible and impactful than ever before. Learn more at IonQ.com.
About DESY
DESY is one of the world’s leading accelerator centers. Researchers use the large-scale facilities at DESY to explore the microcosm in all its variety – from the interactions of tiny elementary particles and the behavior of new types of nanomaterials to biomolecular processes that are essential to life. The accelerators and detectors that DESY develops and builds are unique research tools. The facilities generate the world’s most intense X-ray light, accelerate particles to record energies and open completely new windows onto the universe.
That makes DESY not only a magnet for more than 3000 guest researchers from over 40 countries every year, but also a coveted partner for national and international cooperations. Committed young researchers find an exciting interdisciplinary setting at DESY. The research center offers specialized training for a large number of professions. DESY cooperates with industry and business to promote new technologies that will benefit society and encourage innovations. This also benefits the metropolitan regions of the two DESY locations, Hamburg and Zeuthen near Berlin.
IonQ Forward-Looking Statements
This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Some of the forward-looking statements can be identified by the use of forward-looking words. Statements that are not historical in nature, including the words “expect,” “will,” and other similar expressions are intended to identify forward-looking statements. These statements include those related to: the company’s technology driving commercial advantage in the future; the applicability of IonQ’s quantum computing offerings to multiple use cases; access to IonQ’s quantum computers; the capabilities, scalability, and reliability of IonQ’s quantum computing offerings; the opportunity to test and optimize novel quantum-enhanced algorithms for computational challenges on IonQ’s quantum computers; the accuracy of quantum algorithms run on IonQ’s quantum computers; and the problems that can be solved by IonQ’s quantum computers. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to: changes in the competitive industries in which IonQ operates, including development of competing technologies; changes in laws and regulations affecting IonQ’s business; IonQ’s ability to implement its business plans, forecasts and other expectations, identify and realize partnerships and opportunities, and to engage new and existing customers. You should carefully consider the foregoing factors and the other risks and uncertainties disclosed in the Company’s filings, including but not limited to those described in the “Risk Factors” section of IonQ’s most recent Quarterly Report on Form 10-Q and other documents filed by IonQ from time to time with the Securities and Exchange Commission. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and IonQ assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. IonQ does not give any assurance that it will achieve its expectations.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240314520832/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Owkin Brings Biology Super Intelligence Closer to Reality with New AI Infrastructure for Biological Breakthroughs12.1.2026 18:00:00 CET | Press release
New AI Agents Trained on Millions of Multimodal Datasets Will Speed up Biomedical Research Throughout the Healthcare Ecosystem; Also Announcing New Anthropic Relationship Owkin, the AI company on a mission to solve the complexity of biology, today announced the launch of its agentic infrastructure for biology, making its best-in-class AI agents available to the healthcare ecosystem. The announcement comes at the JPM Healthcare Conference 2026 and follows Owkin’s recent strategic partnerships and its just-announced integration with Claude for Healthcare and Life Sciences by Anthropic. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112461277/en/ Owkin, a 10-year-old AI company with $300 million in funding, is introducing the infrastructure, built on a unique advantage: unparalleled, curated, multimodal patient data from diverse geographies, collected from more than 800 hospitals over a decade. While other companies focus pr
Owkin's Specialized Biological AI Agent Pathology Explorer Launches with Anthropic's Claude for Healthcare and Life Sciences12.1.2026 18:00:00 CET | Press release
First Interoperable AI Agent Trained on Multimodal Patient Data is Accessible Through Model Context Protocol (MCP), Bringing State-of-the-Art Agentic AI to the Healthcare Industry Owkin, an AI company on a mission to solve the complexity of biology, today announced that its interoperable Pathology Explorer AI agent will be included in the launch of Claude for Healthcare and Life Sciences (HCLS) by Anthropic. This marks the first time a highly specialized, world-leading biological agent trained primarily on multimodal patient data is accessible through the Model Context Protocol (MCP) to a broad audience of healthcare and life sciences professionals. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112836381/en/ Owkin's Specialized Biological AI Agent Pathology Explorer Launches with Anthropic's Claude for Healthcare and Life Sciences. The collaboration enables seamless integration of Owkin's advanced pathology analysis capa
Berkshire Hathaway Specialty Insurance Names David Lee Global Chief Human Resources Officer12.1.2026 16:27:00 CET | Press release
Berkshire Hathaway Specialty Insurance (BHSI) today announced the promotion of David Lee to Global Chief Human Resources Officer. “I am thrilled to have David leading our human resources group worldwide,” said Peter Eastwood, President and Chief Executive Officer, BHSI. “An experienced HR practitioner and lifelong student of the profession, his deep expertise, stellar work ethic, and commitment to BHSI values will continue to drive success across our global talent and HR initiatives.” David succeeds Kim Briones, who has led BHSI’s HR group since the company’s founding in 2013 and is retiring from her full-time role. “I want to express my sincere gratitude to Kim for her partnership and friendship over many years and for her outstanding leadership in building our HR function from the ground up,” Peter added. “She has played a pivotal role in growing and developing our company’s greatest asset – our global team of individuals with excellent capabilities and strong character – and in help
Owkin Advances Frontier Model Development for Biological Artificial Super Intelligence, Accelerated by NVIDIA12.1.2026 16:00:00 CET | Press release
Collaboration Leverages NVIDIA's Open Models, AI Infrastructure and Expertise to Build Next-Generation Biological Reasoning Models for Drug Development Owkin, an AI company on a mission to solve the complexity of biology, today announced a collaboration with NVIDIA to enhance OwkinZero, Owkin's biological large reasoning model. The collaboration will leverage NVIDIA's advanced AI computing ecosystem, including the Nemotron family of open models and the NVIDIA NeMo framework to improve the performance, scalability, guardrails, and robustness of Owkin's biological reasoning capabilities to accelerate future breakthroughs in drug discovery and development. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112573701/en/ Owkin Advances Frontier Model Development for Biological Artificial Super Intelligence, Accelerated by NVIDIA. This marks Owkin's first collaboration with NVIDIA and represents a significant milestone in building
SecurityBridge Announces CEO Transition to Accelerate Global Expansion12.1.2026 15:15:00 CET | Press release
SecurityBridge, a leading provider of cybersecurity solutions for SAP, today announced the appointment of Jesper Zerlang as Chief Executive Officer, effective January 1, 2026. Zerlang transitions from his role as Chairman of the Board, a position he has held for the past 12 months, as the company enters its next phase of international expansion, backed by funds advised by BUBregal Unternehmerkapital (BU). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112824449/en/ Jesper Zerlang appointed Chief Executive Officer, SecurityBridge SecurityBridge protects SAP environments for large enterprises by reducing cyber risk across mission-critical SAP landscapes. The company is trusted by global customers to safeguard systems that power core operations, financial processes, supply chains, and digital transformation programs. “SecurityBridge is uniquely positioned at the intersection of cybersecurity and SAP – a domain I know deeply
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
